WNK2 and breast carcinoma: For instance, miR-543 inhibited breast cancer cell proliferation, impeded cell cycle progression and enhanced cell apoptosis by directly repressing downstream factors of the mitogen-activated protein kinase/extracellular signal-regulated kinase-2 (MAPK/ERK2) pathway [30].